These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8875198)

  • 1. Potential markers of aggressiveness in prostatic intraepithelial neoplasia detected by fluorescence in situ hybridization.
    Qian J; Jenkins RB; Bostwick DG
    Eur Urol; 1996; 30(2):177-84. PubMed ID: 8875198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization.
    Qian J; Bostwick DG; Takahashi S; Borell TJ; Herath JF; Lieber MM; Jenkins RB
    Cancer Res; 1995 Nov; 55(22):5408-14. PubMed ID: 7585610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
    Qian J; Jenkins RB; Bostwick DG
    Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
    Jenkins RB; Qian J; Lieber MM; Bostwick DG
    Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and chromosomal alterations in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization.
    Qian J; Jenkins RB; Bostwick DG
    Eur Urol; 1999; 35(5-6):479-83. PubMed ID: 10325509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of gene and chromosome dosage in prostatic intraepithelial neoplasia and carcinoma.
    Qian J; Jenkins RB; Bostwick DG
    Anal Quant Cytol Histol; 1998 Oct; 20(5):373-80. PubMed ID: 9801755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Numerical chromosomal changes in high-grade prostatic intraepithelial neoplasia (PIN) and concomitant invasive carcinoma.
    Erbersdobler A; Gürses N; Henke RP
    Pathol Res Pract; 1996 May; 192(5):418-27. PubMed ID: 8832746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade prostate intraepithelial neoplasia shares cytogenetic alterations with invasive prostate cancer.
    Alcaraz A; Barranco MA; Corral JM; Ribal MJ; Carrió A; Mallofré C; Llopis J; Cetina A; Alvarez-Vijande R
    Prostate; 2001 Apr; 47(1):29-35. PubMed ID: 11304727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic markers in prostatic intraepithelial neoplasia: immunohistochemical and cytogenetic analyses.
    Tsuji M; Kanda K; Murakami Y; Kurokawa Y; Kanayama H; Sano T; Kagawa S
    J Med Invest; 1999 Feb; 46(1-2):35-41. PubMed ID: 10408155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
    Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
    Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of interphase fluorescence in situ hybridization in prostate needle biopsy specimens with isolated high-grade prostatic intraepithelial neoplasia as a predictor of prostate adenocarcinoma on follow-up biopsy.
    Bastacky S; Cieply K; Sherer C; Dhir R; Epstein JI
    Hum Pathol; 2004 Mar; 35(3):281-9. PubMed ID: 15017583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic heterogeneity in a prostatic carcinoma and associated prostatic intraepithelial neoplasia as demonstrated by combined use of laser-microdissection, degenerate oligonucleotide primed PCR and comparative genomic hybridization.
    Zitzelsberger H; Kulka U; Lehmann L; Walch A; Smida J; Aubele M; Lörch T; Höfler H; Bauchinger M; Werner M
    Virchows Arch; 1998 Oct; 433(4):297-304. PubMed ID: 9808430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias.
    Alers JC; Krijtenburg PJ; Vissers KJ; Bosman FT; van der Kwast TH; van Dekken H
    Genes Chromosomes Cancer; 1995 Apr; 12(4):241-50. PubMed ID: 7539277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma.
    Bostwick DG; Shan A; Qian J; Darson M; Maihle NJ; Jenkins RB; Cheng L
    Cancer; 1998 Nov; 83(9):1995-2002. PubMed ID: 9806659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 Alteration and chromosomal instability in prostatic high-grade intraepithelial neoplasia and concurrent carcinoma: analysis by immunohistochemistry, interphase in situ hybridization, and sequencing of laser-captured microdissected specimens.
    Al-Maghrabi J; Vorobyova L; Chapman W; Jewett M; Zielenska M; Squire JA
    Mod Pathol; 2001 Dec; 14(12):1252-62. PubMed ID: 11743048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN).
    Koeneman KS; Pan CX; Jin JK; Pyle JM; Flanigan RC; Shankey TV; Diaz MO
    J Urol; 1998 Oct; 160(4):1533-9. PubMed ID: 9751408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma.
    Vukovic B; Park PC; Al-Maghrabi J; Beheshti B; Sweet J; Evans A; Trachtenberg J; Squire J
    Oncogene; 2003 Apr; 22(13):1978-87. PubMed ID: 12673203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization.
    Gburek BM; Kollmorgen TA; Qian J; D'Souza-Gburek SM; Lieber MM; Jenkins RB
    J Urol; 1997 Jan; 157(1):223-7. PubMed ID: 8976257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
    Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of loss of heterozygosity on chromosome 8 in human prostate carcinoma and high grade prostatic intraepithelial neoplasia].
    Wang Z; Lai FM
    Zhonghua Nan Ke Xue; 2004 Jan; 10(1):26-8, 31. PubMed ID: 14979203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.